Drug
Treprostinil Diethanolamine
Treprostinil Diethanolamine: highest development phase Phase 1, developed by United Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- United Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Treprostinil diethanolamine NCT00963027 | Phase 1 | Hypertension, Pulmonary |
| Treprostinil diethanolamine NCT01153386 | Phase 1 | Pulmonary Arterial Hypertension |
Latest
No recent events.
Follow Treprostinil Diethanolamine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.